Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195103 · ClinicalTrials.gov registry record · Phase 4
Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery
A Phase 4 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT01195103: Clinical Trial Phase 4 study, sponsored by Mayo Clinic.
NCT01195103 is a Phase 4 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01195103, a Phase 4 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
How does Lusedra compare with current standard of care (midazolam) for minimal to moderate sedation for regional anesthesia blocks prior to orthopedic surgery?
Interventions
- DRUG Fentanyl
- DRUG Fospropofol disodium
- DRUG Placebo + Midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-02 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01195103
The ClinicalTrials.gov registry entry for NCT01195103 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Fentanyl is the first listed.
NCT01195103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01195103 about?
NCT01195103 is a clinical study titled "Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery". How does Lusedra compare with current standard of care (midazolam) for minimal to moderate sedation for regional anesthesia blocks prior to orthopedic surgery?
What is the current status of trial NCT01195103?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2011-02. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01195103?
The interventions under investigation include: Fentanyl (DRUG), Fospropofol disodium (DRUG), Placebo + Midazolam (DRUG).
Who is sponsoring clinical trial NCT01195103?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.